In the closing weeks of 2024, USPTO Director Kathi Vidal announced her departure in a November LinkedIn post, stating that she would leave the ...
ANORTECH INC. (“AnorTech” or the “Company”) (TSX Venture Exchange “ANOR”; OTC “ANORF”) is pleased to announce that it has filed a provisional patent with the United States Patent and Trademark Office ...
The Company's patent pending silicon-enhanced spheroidized graphite technology represents a breakthrough in lithium-ion ...
GM has filed a patent application for a new EV charge port weather shield designed to enhance safety and durability for those ...
4d
GlobalData on MSNEton secures US patent for diabetes insipidus treatmentEton has secured a patent from the USPTO for its ET-600 product candidate’s desmopressin oral solution formulation for ...
1d
New Vision on MSNMagoola says cancer treatment invention awarded US patentKAMPALA - Dr Matthias Magoola says the US Patent and Trademark Office (USPTO) has granted a patent for his invention of the first treatment of cancer using a novel composition of a guided Ribonucleic ...
With the recent convocation of the 119th Congress, a change in administration, and resignation of USPTO Director Vidal, pharmaceutical patent ...
Nintendo and The Pokémon Company recently received two new U.S. patents related to game mechanics, such as capturing and ...
Oracle refuses to give up the JavaScript trademark, sparking backlash from developers. Could its control impact the language?
Additions broaden DehydraTECH patent suite for Epilepsy KELOWNA, BC / ACCESS Newswire / February 11, 2025 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results